Gallo JM - Search Results

1

Screening candidate anticancer drugs for brain tumor chemotherapy: pharmacokinetic-driven approach for a series of (E)-N-(substituted aryl)-3-(substituted phenyl)propenamide analogues.

Lv H, Wang F, Reddy MV, Zhou Q, Zhang X, Reddy EP, Gallo JM. Lv H, et al. Among authors: gallo jm. Invest New Drugs. 2012 Dec;30(6):2263-73. doi: 10.1007/s10637-012-9806-x. Epub 2012 Mar 1. Invest New Drugs. 2012. PMID: 22383114 Free PMC article.

2

In vivo microdialysis for PK and PD studies of anticancer drugs.

Zhou Q, Gallo JM. Zhou Q, et al. Among authors: gallo jm. AAPS J. 2005 Oct 24;7(3):E659-67. doi: 10.1208/aapsj070366. AAPS J. 2005. PMID: 16353942 Free PMC article. Review.

3

Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide dosing regimens.

Zhou Q, Guo P, Wang X, Nuthalapati S, Gallo JM. Zhou Q, et al. Among authors: gallo jm. J Pharmacol Exp Ther. 2007 Apr;321(1):265-75. doi: 10.1124/jpet.106.118265. Epub 2007 Jan 26. J Pharmacol Exp Ther. 2007. PMID: 17259446

4

Predicting human tumor drug concentrations from a preclinical pharmacokinetic model of temozolomide brain disposition.

Zhou Q, Guo P, Kruh GD, Vicini P, Wang X, Gallo JM. Zhou Q, et al. Among authors: gallo jm. Clin Cancer Res. 2007 Jul 15;13(14):4271-9. doi: 10.1158/1078-0432.CCR-07-0658. Clin Cancer Res. 2007. PMID: 17634557

5

Preclinical pharmacokinetic/pharmacodynamic models of gefitinib and the design of equivalent dosing regimens in EGFR wild-type and mutant tumor models.

Wang S, Guo P, Wang X, Zhou Q, Gallo JM. Wang S, et al. Among authors: gallo jm. Mol Cancer Ther. 2008 Feb;7(2):407-17. doi: 10.1158/1535-7163.MCT-07-2070. Mol Cancer Ther. 2008. PMID: 18281523

6

Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide.

Zhou Q, Guo P, Gallo JM. Zhou Q, et al. Among authors: gallo jm. Clin Cancer Res. 2008 Mar 1;14(5):1540-9. doi: 10.1158/1078-0432.CCR-07-4544. Clin Cancer Res. 2008. PMID: 18316579

7

Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model.

Zhou Q, Gallo JM. Zhou Q, et al. Among authors: gallo jm. Neuro Oncol. 2009 Jun;11(3):301-10. doi: 10.1215/15228517-2008-088. Epub 2008 Oct 29. Neuro Oncol. 2009. PMID: 18971416 Free PMC article.

8

Demonstration of the equivalent pharmacokinetic/pharmacodynamic dosing strategy in a multiple-dose study of gefitinib.

Wang S, Zhou Q, Gallo JM. Wang S, et al. Among authors: gallo jm. Mol Cancer Ther. 2009 Jun;8(6):1438-47. doi: 10.1158/1535-7163.MCT-09-0089. Epub 2009 Jun 9. Mol Cancer Ther. 2009. PMID: 19509243 Free PMC article.

9

New strategies to deliver anticancer drugs to brain tumors.

Laquintana V, Trapani A, Denora N, Wang F, Gallo JM, Trapani G. Laquintana V, et al. Among authors: gallo jm. Expert Opin Drug Deliv. 2009 Oct;6(10):1017-32. doi: 10.1517/17425240903167942. Expert Opin Drug Deliv. 2009. PMID: 19732031 Free PMC article. Review.

10

Quantification of sunitinib in mouse plasma, brain tumor and normal brain using liquid chromatography-electrospray ionization-tandem mass spectrometry and pharmacokinetic application.

Zhou Q, Gallo JM. Zhou Q, et al. Among authors: gallo jm. J Pharm Biomed Anal. 2010 Mar 11;51(4):958-64. doi: 10.1016/j.jpba.2009.10.006. Epub 2009 Oct 12. J Pharm Biomed Anal. 2010. PMID: 19896317 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters